TW255894B - - Google Patents

Info

Publication number
TW255894B
TW255894B TW082108775A TW82108775A TW255894B TW 255894 B TW255894 B TW 255894B TW 082108775 A TW082108775 A TW 082108775A TW 82108775 A TW82108775 A TW 82108775A TW 255894 B TW255894 B TW 255894B
Authority
TW
Taiwan
Application number
TW082108775A
Other languages
Chinese (zh)
Original Assignee
Fujisawa Yakusin Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929222291A external-priority patent/GB9222291D0/en
Priority claimed from GB939314495A external-priority patent/GB9314495D0/en
Application filed by Fujisawa Yakusin Kogyo Kk filed Critical Fujisawa Yakusin Kogyo Kk
Application granted granted Critical
Publication of TW255894B publication Critical patent/TW255894B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
TW082108775A 1992-10-23 1993-10-21 TW255894B (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929222291A GB9222291D0 (en) 1992-10-23 1992-10-23 New cephem compounds
GB939314495A GB9314495D0 (en) 1993-07-12 1993-07-12 New cephem compounds

Publications (1)

Publication Number Publication Date
TW255894B true TW255894B (enrdf_load_stackoverflow) 1995-09-01

Family

ID=26301852

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082108775A TW255894B (enrdf_load_stackoverflow) 1992-10-23 1993-10-21

Country Status (9)

Country Link
EP (1) EP0665847A1 (enrdf_load_stackoverflow)
JP (1) JPH08502513A (enrdf_load_stackoverflow)
KR (1) KR950704331A (enrdf_load_stackoverflow)
CN (1) CN1144222A (enrdf_load_stackoverflow)
CA (1) CA2147609A1 (enrdf_load_stackoverflow)
IL (1) IL107359A0 (enrdf_load_stackoverflow)
MX (1) MX9306572A (enrdf_load_stackoverflow)
TW (1) TW255894B (enrdf_load_stackoverflow)
WO (1) WO1994010177A1 (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2281090T3 (es) 1996-11-06 2007-09-16 Basilea Pharmaceutica Ag Derivados de vinilpirrolidona-cefalosporina.
TW415949B (en) * 1996-12-19 2000-12-21 Hoffmann La Roche Vinyl pyrrolidine cephalosporin derivatives with basic substituents
EP1201665B1 (en) * 1999-07-30 2004-09-29 Eisai Co., Ltd. Process for the preparation of basic antibiotic-inorganic acid addition salts and intermediate oxalates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546101A (en) * 1982-09-10 1985-10-08 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds useful for treating infectious diseases in human being and animals and processes for preparation thereof
GB8519606D0 (en) * 1985-08-05 1985-09-11 Fujisawa Pharmaceutical Co 3 7-d substituted-3-cephem compounds
JPH0686463B2 (ja) * 1988-07-01 1994-11-02 明治製菓株式会社 新規セフェム化合物、その製造法及び抗菌剤

Also Published As

Publication number Publication date
WO1994010177A1 (en) 1994-05-11
CA2147609A1 (en) 1994-05-11
JPH08502513A (ja) 1996-03-19
MX9306572A (es) 1994-04-29
EP0665847A1 (en) 1995-08-09
CN1144222A (zh) 1997-03-05
KR950704331A (ko) 1995-11-17
IL107359A0 (en) 1994-01-25

Similar Documents

Publication Publication Date Title
DK0553875T3 (enrdf_load_stackoverflow)
TW267176B (enrdf_load_stackoverflow)
TW224450B (enrdf_load_stackoverflow)
TW248536B (enrdf_load_stackoverflow)
TW232646B (enrdf_load_stackoverflow)
DK0576346T3 (enrdf_load_stackoverflow)
DK0596750T3 (enrdf_load_stackoverflow)
DK0554977T3 (enrdf_load_stackoverflow)
BR9207065A (enrdf_load_stackoverflow)
DK0553681T3 (enrdf_load_stackoverflow)
DK0581129T3 (enrdf_load_stackoverflow)
DK0574276T3 (enrdf_load_stackoverflow)
DK0564197T3 (enrdf_load_stackoverflow)
DK0596569T3 (enrdf_load_stackoverflow)
TW255894B (enrdf_load_stackoverflow)
FR2686406B1 (enrdf_load_stackoverflow)
DK0576097T3 (enrdf_load_stackoverflow)
DK0559942T3 (enrdf_load_stackoverflow)
DK0590732T3 (enrdf_load_stackoverflow)
TW243419B (enrdf_load_stackoverflow)
IN175196B (enrdf_load_stackoverflow)
IN177468B (enrdf_load_stackoverflow)
IN177358B (enrdf_load_stackoverflow)
IN183069B (enrdf_load_stackoverflow)
IN180798B (enrdf_load_stackoverflow)